Definium Therapeutics, Inc. (DFTX)
16.23
-1.12
(-6.46%)
USD |
NASDAQ |
Feb 12, 16:00
16.41
+0.18
(+1.11%)
After-Hours: 04:47
Definium Therapeutics Total Liabilities (Quarterly) : 106.32M for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Pulse Biosciences, Inc. | 16.07M |
| RxSight, Inc. | 32.56M |
| Plus Therapeutics, Inc. | 13.62M |
| Viridian Therapeutics, Inc. | 74.17M |
| Nutriband, Inc. | 0.8702M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 236.92M |
| Shareholders Equity (Quarterly) | 130.60M |
| Debt to Equity Ratio | 0.3092 |
| Current Ratio | 3.300 |
| Net Debt Paydown Yield | -0.36% |